Drug Shortage Report for KETALAR

Last updated on 2023-10-07 History
Report ID 186132
Drug Identification Number 00224391
Brand name KETALAR
Common or Proper name Ketalar
Company Name SEARCHLIGHT PHARMA INC
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 20ml
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2023-03-26
Actual start date 2023-03-27
Estimated end date 2023-10-06
Actual end date 2023-10-06
Shortage status Resolved
Updated date 2023-10-07
Company comments Product is currently on allocation.
Health Canada comments
Tier 3 Status No
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2023-10-07 English Compare
v14 2023-10-05 French Compare
v13 2023-10-05 English Compare
v12 2023-09-28 French Compare
v11 2023-09-28 English Compare
v10 2023-03-28 English Compare
v9 2023-03-27 French Compare
v8 2023-03-27 English Compare
v7 2023-03-27 English Compare
v6 2023-03-27 French Compare
v5 2023-03-27 English Compare
v4 2023-03-27 English Compare
v3 2023-03-27 English Compare
v2 2023-03-03 French Compare
v1 2023-03-03 English Compare

Showing 1 to 15 of 15